Healthcare - Biotechnology - NASDAQ - US
$ 2.5
-6.72 %
$ 4.94 M
Market Cap
-0.22
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
41.42%
Net Income
Estimate
75.61%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
180 Life Sciences Corp.
ATNF has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ATNF
EBIT FORECAST
EBIT Forecast Chart ATNF
NET INCOME FORECAST
Net Income Chart ATNF